LABORATORY RESEARCH G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression Scientists showed that euchromatin histone methyltransferase 2 (G9a) functions as a coactivator of the endogenous estrogen receptor α (ERα) in breast cancer cells in a histone methylation-independent manner. [Nat Commun] Full Article Genetic Suppression Reveals DNA Repair-Independent Antagonism between BRCA1 and COBRA1 in Mammary Gland Development Scientists interrogated the functional interaction between BRCA1 and COBRA1 during mouse mammary gland development. Tissue-specific deletion of Cobra1 reduced mammary epithelial compartments and blocked ductal morphogenesis, alveologenesis and lactogenesis, demonstrating a pivotal role of COBRA1 in adult tissue development. [Nat Commun] Full Article Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression Scientists used ErbB2 mouse models of human breast cancer to investigate rab coupling protein (FIP1C) function in tumorigenesis. Doxycycline-induced expression of FIP1C in the MMTV-ErbB2 mouse model resulted in delayed mammary tumor progression. [Cancer Res] Abstract Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1 Researchers showed that estrogen dependent PAK1 is activated through both the estrogen receptor α (ERα) and GPER1 membrane receptors. Estrogen-dependent activation of PAK1 required the phosphorylation of tyrosine residues by Etk/Bmx and protein kinase A (PKA) within an assembled signaling complex comprising pTyr-PAK1, Etk/Bmx, the heterotrimer G-protein subunits Gβ1, Gγ2 and/or Gγ5, PAK-associated guanine nucleotide exchange factor, and PKA. [Cancer Res] Abstract Neither Epithelial nor Mesenchymal Circulating Tumor Cells Isolated from Breast Cancer Patients Are Tumorigenic in NOD-scid Il2rgnull Mice Scientists investigated the tumorigenic potential of circulating EpCAM+ tumor cells from cryopreserved mobilized leukapheresis products obtained from three metastatic breast cancer patients in remission. [Sci Rep] Full Article MYC Functions Are Specific in Biological Subtypes of Breast Cancer and Confers Resistance to Endocrine Therapy in Luminal Tumors The authors hypothesised that the functional role of c-MYC differs between molecular subtypes of breast cancers. [Br J Cancer] Abstract Epigenetic Suppression of Neprilysin Regulates Breast Cancer Invasion Investigators asked whether neprilysin expression predicts and functionally regulates breast cancer cell invasion. RT–PCR and flow cytometry analysis of MDA-MB-231 and MCF-7 breast cancer cell lines revealed decreased neprilysin expression compared with normal epithelial cells. [Oncogenesis] Full Article CLINICAL RESEARCH Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer Researchers investigated whether the efficacy of trastuzumab emtansine, an antibody-drug conjugate comprised of the cytotoxic agent DM1 linked to the HER2-targeted antibody trastuzumab, was correlated with expression of specific biomarkers in the Phase III EMILIA study. [Clin Cancer Res] Abstract | Full Article Genetic Alterations of Triple Negative Breast Cancer by Targeted Next-Generation Sequencing and Correlation with Tumor Morphology Researchers defined the genetic alterations in 39 triple negative breast cancers using a high-depth targeted massively parallel sequencing assay and correlated the findings with a detailed morphologic analysis. [Mod Pathol] Abstract Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers Scientists hypothesized that Fluorine-18-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-Fluciclovine) may provide a novel method of visualizing breast cancer and now report a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed advanced local invasive ductal carcinoma and invasive lobular carcinoma. [J Nucl Med] Abstract |